Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
PC, Pancreatic Cancer: Click to Expand ⟱
Pancreatic Cancer: Hypoxia (low oxygen tension) is commonly found in solid tumors. Hypoxia-inducible factor-1 (HIF-1),is a key mediator of the cellular response to hypoxia and is overexpressed in a wide variety of solid tumors, including pancreatic cancer.
Nanog is highly expressed in CSCs compared to normal cells [93–97]
HIF-1↑
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
- |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
mtDam↑, ROS↑, *toxicity↓, Dose∅, selectivity↑,
| - |
in-vitro, |
Nor, |
HDFa |
|
|
|
- |
in-vitro, |
PC, |
AsPC-1 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
selectivity↑, selectivity↑, selectivity↓, ROS↑, eff↑, tumCV↓, MMP↓, Dose∅, eff↓, DNAdam↑, Apoptosis↑, TumAuto↑, Necroptosis↑, p‑P53↑, BIM↑, BAX↑, p‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Cyt‑c↑, Bcl-2↓, AIF↑, p62↑, LC3B↑, MLKL↑, p‑MLKL↓, RIP3↑, p‑RIP3↑, TumCG↑, TumW↓,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
Nor, |
H6c7 |
|
|
|
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,
| - |
in-vitro, |
PC, |
SK-N-BE |
|
|
|
- |
NA, |
PC, |
PANC1 |
|
|
|
p‑PDH↓, GlucoseCon↓, lactateProd↓, MMP↓, Casp3↑, eff↑, PDKs↓, selectivity↑, TumCG↓, Dose∅, MMP↓, ROS∅, toxicity↑, antiOx↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, ROS↑, 3, ROS∅, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↑, 1, MMP↓, 4, mtDam↑, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↓, 1, lactateProd↓, 1, p‑PDH↓, 1, PDKs↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, BIM↑, 1, Casp3↑, 2, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 1, p‑JNK↑, 1, MLKL↑, 1, p‑MLKL↓, 1, Necroptosis↑, 1, p‑p38↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 2,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3B↑, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, p‑P53↑, 1, p‑PARP↑, 1, cl‑PARP↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑ERK↓, 1, TumCG↓, 1, TumCG↑, 1,
Migration(tgid=13) ⓘ
RIP3↑, 1, p‑RIP3↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose∅, 4, eff↓, 2, eff↑, 3, selectivity↓, 1, selectivity↑, 5,
Functional Outcomes(tgid=23) ⓘ
toxicity↑, 1, TumW↓, 1,
Total Targets: 44
Pathway results for Effect on Normal Cells:
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:21 Cells:% prod#:% Target#:1114 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page